Filing Details
- Accession Number:
- 0001846487-23-000003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-13 16:02:30
- Reporting Period:
- 2023-11-10
- Accepted Time:
- 2023-11-13 16:02:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1023024 | Ani Pharmaceuticals Inc | ANIP | Pharmaceutical Preparations (2834) | 582301143 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1846487 | Christopher Mutz | C/O Ani Pharmaceuticals, Inc. 210 Main Street West Baudette MN 56623 | Head Of Rare Disease | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-11-10 | 3,000 | $52.47 | 63,607 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $52.41 to $52.58, inclusive.
Billionaire Hedge Funds
